Founded immune markers still protect their relevance for medical decision-earning in breast cancer remedy with even extended meanings. Estrogen receptor (ER) level shouldn't only be classified in positive or unfavorable. Lower ER levels ≤ten% of labeled cells ought to be handled otherwise (LoE 1a/A/Back++). Tumors with lower ER amounts https://ignacyn521lwf1.wikiparticularization.com/user